Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,099 public trials 2,041 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Platform Study for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (PRISM Study)

NCT03527147

Conditions
DLBCL, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +12 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Sarasota, Florida, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site New Orleans, Louisiana, United States
View Trial Details
Completed

Study of Tisagenlecleucel in Combination With Pembrolizumab in r/r Diffuse Large B-cell Lymphoma Patients

NCT03630159

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Emory University School of Medicine SC CTL019 Atlanta, Georgia, United States
  • University of Chicago Medical Center Hematology and Oncology Chicago, Illinois, United States
  • University of Kansas Hospital and Medical Center U of Kansas Cancer Center Kansas City, Kansas, United States
  • Novartis Investigative Site Vienna, Austria
View Trial Details
Completed

A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)

NCT01332968

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • The Regents of the University of California; Office of Research Irvine, California, United States
  • Kootenai Cancer Center Post Falls, Idaho, United States
  • Illinois Cancer Care, P.C. - Galesburg Galesburg, Illinois, United States
View all 183 locations
View Trial Details
Completed

A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or Sarcoidosis

NCT03727451

Conditions
Cardiovascular Diseases, Fibrosis, Hemic and Lymphatic Diseases, +17 more
Locations
  • University of Miami Miami, Florida, United States
  • University of Cincinnati Cincinnati, Ohio, United States
  • Temple University Philadelphia, Pennsylvania, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
View Trial Details

Related conditions